// App-Quantinova.ai

3585 : Expanded Therapeutic Index Of Antithrombin Silencing and Correction Of Aptt In a Hemophilia A Mouse Model

Researchers

Presenter

  • Scott A Barros

Principal Investigators

  • Mary Carioto

  • Julia Hettinger

  • Yongfeng Jiang

  • June Qin

  • Harsha Prabhala

  • Alfica Sehgal

  • Akin Akinc

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Alnylam Pharmaceutic

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Disseminated intravascular coagulation

  • Hemophilia

  • Venous thrombosis

Biomarkers

  • N-Acylethanolamine acid amidase

  • erb-b2 receptor tyrosine kinase 2

  • Translocator protein

Drug/Treatment

  • Hemostatic Solution

  • ALN-AT3

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved